Simon Mallal
Simon Mallal
Director, Institute for Immunology and Infectious Diseases, Murdoch University, Western Australia
Verified email at iiid.com.au
Title
Cited by
Cited by
Year
Combination antiretroviral therapy and the risk of myocardial infarction
Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group
New England Journal of Medicine 349 (21), 1993-2003, 2003
20052003
HLA-B* 5701 screening for hypersensitivity to abacavir
S Mallal, E Phillips, G Carosi, JM Molina, C Workman, J Tomažič, ...
New England Journal of Medicine 358 (6), 568-579, 2008
18372008
Association between presence of HLA-B* 5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir
S Mallal, D Nolan, C Witt, G Masel, AM Martin, C Moore, D Sayer, ...
The Lancet 359 (9308), 727-732, 2002
15272002
A whole-genome association study of major determinants for host control of HIV-1
J Fellay, KV Shianna, D Ge, S Colombo, B Ledergerber, M Weale, ...
science 317 (5840), 944-947, 2007
13362007
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D: A: D study: a multi-cohort collaboration
D: A: D Study Group
The Lancet 371 (9622), 1417-1426, 2008
10392008
Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA
P Kiepiela, AJ Leslie, I Honeyborne, D Ramduth, C Thobakgale, S Chetty, ...
Nature 432 (7018), 769-775, 2004
9012004
Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level
CB Moore, M John, IR James, FT Christiansen, CS Witt, SA Mallal
Science 296 (5572), 1439-1443, 2002
8892002
Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection
SA Mallal, M John, CB Moore, IR James, EJ McKinnon
Aids 14 (10), 1309-1316, 2000
6002000
The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases
P Price, C Witt, R Allock, D Sayer, M Garlepp, CC Kok, M French, S Mallal, ...
Immunological reviews 167 (1), 257-274, 1999
5731999
Immune restoration disease after the treatment of immunodeficient HIV‐infected patients with highly active antiretroviral therapy
MA French, N Lenzo, M John, SA Mallal, EJ McKinnon, IR James, P Price, ...
HIV medicine 1 (2), 107-115, 2000
5152000
Adaptation of HIV-1 to human leukocyte antigen class I
Y Kawashima, K Pfafferott, J Frater, P Matthews, R Payne, M Addo, ...
Nature 458 (7238), 641-645, 2009
5132009
Predisposition to abacavir hypersensitivity conferred by HLA-B* 5701 and a haplotypic Hsp70-Hom variant
AM Martin, D Nolan, S Gaudieri, CA Almeida, R Nolan, I James, ...
Proceedings of the National Academy of Sciences 101 (12), 4180-4185, 2004
5112004
Common genetic variation and the control of HIV-1 in humans
J Fellay, D Ge, KV Shianna, S Colombo, B Ledergerber, ET Cirulli, ...
PLoS Genet 5 (12), e1000791, 2009
4042009
Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes
B Ledergerber, PLATO collaboration
The Lancet 364 (9428), 51-62, 2004
3782004
Effects of CCR5-32, CCR2-64I, and SDF-1 3 A Alleles on HIV-1 Disease Progression: An International Meta-Analysis of Individual-Patient Data
IP Data
Ann Intern Med 135, 782-795, 2001
364*2001
Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 …
TM Allen, M Altfeld, SC Geer, ET Kalife, C Moore, KM O'sullivan, ...
Journal of virology 79 (21), 13239-13249, 2005
3602005
High sensitivity of human leukocyte antigen-b* 5701 as a marker for immunologically confirmed abacavir hypersensitivity in white and black patients
M Saag, R Balu, E Phillips, P Brachman, C Martorell, W Burman, B Stancil, ...
Clinical infectious diseases 46 (7), 1111-1118, 2008
3582008
Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans
J Mateus, A Grifoni, A Tarke, J Sidney, SI Ramirez, JM Dan, ZC Burger, ...
Science 370 (6512), 89-94, 2020
3572020
Predisposition to nevirapine hypersensitivity associated with HLA-DRB1* 0101 and abrogated by low CD4 T-cell counts
AM Martin, D Nolan, I James, P Cameron, J Keller, C Moore, E Phillips, ...
Aids 19 (1), 97-99, 2005
3512005
T cells from patients with Parkinson’s disease recognize α-synuclein peptides
D Sulzer, RN Alcalay, F Garretti, L Cote, E Kanter, J Agin-Liebes, C Liong, ...
Nature 546 (7660), 656-661, 2017
3492017
The system can't perform the operation now. Try again later.
Articles 1–20